New potential anti-SARS-CoV-2 and anti-cancer therapies of chitosan derivatives and its nanoparticles: Preparation and characterization

被引:11
|
作者
Ali, Mai [1 ]
Mohamed, Mansoura I. [2 ]
Taher, Azza T. [3 ,4 ]
Mahmoud, Sara H. [5 ]
Mostafa, Ahmed [5 ]
Sherbiny, Farag F. [6 ,7 ,8 ]
Kandile, Nadia G. [2 ]
Mohamed, Hemat M. [2 ]
机构
[1] October 6 Univ O6U, Fac Pharm, Dept Chem, October 6 City 12585, Giza, Egypt
[2] Ain Shams Univ, Fac Women Art Sci & Educ, Chem Dept, Cairo 11757, Egypt
[3] Cairo Univ, Fac Pharm, Dept Pharmaceut Organ Chem, Cairo 11562, Egypt
[4] October 6 Univ O6U, Fac Pharm, Dept Pharmaceut Organ Chem, October 6 City 12585, Giza, Egypt
[5] Natl Res Ctr, Ctr Sci Excellence Influenza Viruses, Giza 12622, Egypt
[6] Al Azhar Univ, Fac Pharm Boys, Pharmaceut Organ Chem Dept, Cairo 11884, Egypt
[7] Misr Univ Sci & Technol MUST, Basic Sci Ctr, Dept Chem, 6th Of The October City 77, Egypt
[8] Misr Univ Sci & Technol MUST, Pharmaceut Organ Chem Coll Pharmaceut Sci & Drug M, 6th Of The October City, Egypt
关键词
Chitosan and chitosan NP?s derivatives; COVID-19; Anticancer; Molecular docking; ANTIVIRAL ACTIVITY; DESIGN; ISATIN;
D O I
10.1016/j.arabjc.2023.104676
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Chitosan (CS) is a biopolymer and has reactive amine/hydroxyl groups facilitated its modifications. The purpose of this study is improvement of (CS) physicochemical properties and its capabilities as antiviral and antitumor through modification with 1-(2-oxoindolin-3-ylidene)thio semicarbazide (3A) or 1-(5-fluoro-2-oxoindolin-3-ylidene)thiosemicarbazide (3B) via crosslinking of poly(ethylene glycol)diglycidylether (PEGDGE) using microwave-assisted as green technique gives (CS-I) and (CS-II) derivatives. However, (CS) derivatives nanoparticles (CS-I NPs) and (CS-II NPs) are synthesized via ionic gelation technique using sodium tripolyphosphate (TPP). Structures of new (CS) derivatives are characterized using different tools. The anticancer, antiviral efficiencies and molecular docking of (CS) and its derivatives are assayed. (CS) derivatives and its nanoparticles
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Facial Diplegia Complicating Anti-SARS-CoV-2 Vaccinations
    Finsterer, Josef
    NEUROHOSPITALIST, 2023, 13 (01): : 113 - 114
  • [42] Identification and characterization of the anti-SARS-CoV-2 activity of cationic amphiphilic steroidal compounds
    Borin, Alexandre
    Coimbra, Lais D.
    Bispo-dos-Santos, Karina
    Naciuk, Fabricio F.
    Fontoura, Marina
    Simeoni, Camila L.
    Gomes, Giovanni, V
    Amorim, Mariene R.
    Gravina, Humberto D.
    Shimizu, Jacqueline Farinha
    Passos, Amanda S. C.
    de Oliveira, Isadora M.
    de Carvalho, Ana Carolina
    Cardoso, Alisson Campos
    Parise, Pierina L.
    Toledo-Teixeira, Daniel A.
    Sotorilli, Giuliana E.
    Persinoti, Gabriela F.
    Claro, Ingra Morales
    Sabino, Ester C.
    Alborghetti, Marcos R.
    Rocco, Silvana A.
    Franchini, Kleber G.
    de Souza, William M.
    Oliveira, Paulo S. L.
    Cunha, Thiago M.
    Granja, Fabiana
    Proenca-Modena, Jose Luiz
    Trivella, Daniela B. B.
    Bruder, Marjorie
    Cordeiro, Artur T.
    Marques, Rafael Elias
    VIRULENCE, 2022, 13 (01) : 1031 - 1048
  • [43] Anti-SARS-CoV-2 Antibody Testing: Role and Indications
    Mink, Sylvia
    Fraunberger, Peter
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (24)
  • [44] WHO International Standard for anti-SARS-CoV-2 immunoglobulin
    Kristiansen, Paul A.
    Page, Mark
    Bernasconi, Valentina
    Mattiuzzo, Giada
    Dull, Peter
    Makar, Karen
    Plotkin, Stanley
    Knezevic, Ivana
    LANCET, 2021, 397 (10282): : 1347 - 1348
  • [45] Development and characterization of a quantitative ELISA to detect anti-SARS-CoV-2 spike antibodies
    Zak, Magdalena M.
    Stock, Aryeh
    Stadlbauer, Daniel
    Zhang, Wei
    Cummings, Kirstie
    Marsiglia, William
    Zargarov, Arsen
    Amanat, Fatima
    Tamayo, Monica
    Cordon-Cardo, Carlos
    Krammer, Florian
    Mendu, Damodara Rao
    HELIYON, 2021, 7 (12)
  • [46] Immunoassays for anti-SARS-CoV-2 antibodies: recent insights
    Van Elslande, Jan
    Andre, Emmanuel
    Van Ranst, Marc
    Lagrou, Katrien
    Vermeersch, Pieter
    LANCET INFECTIOUS DISEASES, 2021, 21 (05): : E118 - E118
  • [47] Injectable niclosamide nanohybrid as an anti-SARS-CoV-2 strategy
    Rejinold, N. Sanoj
    Piao, Huiyan
    Jin, Geun-woo
    Choi, Goeun
    Choy, Jin-Ho
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2021, 208
  • [48] Editorial: The Mechanisms of Action of Anti-SARS-CoV-2 Drugs
    Zhong, Wu
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [49] Epitope Analysis of Anti-SARS-CoV-2 Neutralizing Antibodies
    Jun-biao Xue
    Sheng-ce Tao
    Current Medical Science, 2021, 41 : 1065 - 1074
  • [50] Anti-SARS-CoV-2 monoclonal antibodies: an opportunity to be seized
    不详
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2021, 205 (05): : 431 - 432